Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands

Published by: Euromonitor International

Published: Apr. 1, 2008

Table of Contents

OTC HEALTHCARE IN THE NETHERLANDS

Executive Summary

New Medicine Law

Strong Growth in Medicines Targeted at Older Consumers

International Players Dominate

Private Label Products Increase Their OTC Penetration

Child-specific Remedies Show Good Growth

Key Trends and Developments

Good Prospects for Targeting the Ageing Population

Health and Wellness Becoming Increasingly Important

Private Label Products A Force for the Future

Consumers Lead Increasingly Busy Lifestyles

Interest in Preventative Medicine Helping Growth of Herbal Products

Consumer and Retailer Education Increasingly Important

The Dutch OTC Market Is Reaching Maturity

Market Indicators

Table 1 Life Expectancy at Birth 2001-2006

Market Data

Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006

Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006

Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006

Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006

Table 6 Penetration of Private Label by Sector 2002-2006

Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006

Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006

Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011

Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011

Appendix

OTC Registration and Classification

Advertising

Distribution

Vitamins and Dietary Supplements Registration and Classification

Generics

Consumer Expenditure on Health Goods and Medical Services

Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006

Definitions

Sources

Summary 1 Research Sources

LOCAL COMPANY PROFILES - NETHERLANDS

Bional Pharma BV

Strategic Direction

Key Facts

Summary 2 Bional Pharma BV: Key Facts

Summary 3 Bional Pharma BV: Operational Indicators 2005

Company Background

Production

Competitive Positioning

Summary 4 Bional Pharma BV: Competitive Position 2006

Chefaro International BV

Strategic Direction

Key Facts

Summary 5 Chefaro International BV: Key Facts

Summary 6 Chefaro International BV: Operational Indicators 2004-2005

Company Background

Production

Competitive Positioning

Summary 7 Chefaro International BV: Competitive Position 2006

Kernpharm BV

Strategic Direction

Key Facts

Summary 8 Kernpharm BV: Key Facts

Company Background

Production

Competitive Positioning

Summary 9 Kernpharm BV: Competitive Position 2006

Nl Pharma BV

Strategic Direction

Key Facts

Summary 10 NL Pharma BV Key Facts

Company Background

Competitive Positioning

Summary 11 NL Pharma BV Competitive Position 2006

Viatris BV

Strategic Direction

Key Facts

Summary 12 Viatris BV: Key Facts

Company Background

Production

Competitive Positioning

Summary 13 Viatris BV: Competitive Position 2006

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE NETHERLANDS

Headlines

Trends

Competitive Landscape

Prospects

Sector Data

Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006

Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006

Table 14 Sales of Decongestants by Type: Value 2001-2006

Table 15 Sales of Decongestants by Type: % Value Growth 2001-2006

Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006

Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006

Table 18 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006

Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006

Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006

Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011

Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011

Abstract

Euromonitor International's Cough, Cold and Allergy Products in the Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the cough, cold and allergy (hayfever) industry
• Identify factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis and Dubai and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.